<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Healthcare expenditure and CVD incidence</title>
    <link rel="stylesheet" href="styles.css">
</head>
<body>
    <main>
        <article class="blog-post">
            <h2>The Impact of Federal Investment in Public Health on Cardiovascular Disease Incidence:
                 A Comparative Analysis (2000-2020)</h2>
            <p class="date">Published on [Date]</p>

            <p>I have always believed that government spending on education and healthcare should be seen 
                not as expenses, but as investments. Investing in healthcare, for example, can improve 
                the overall health of the population, enhance quality of life, and strengthen the national 
                workforce. This, in turn, boosts productivity and reduces early retirements and work 
                absences due to health issues, lessening the strain on social security. Let's consider the 
                case of cardiovascular diseases. This essay examines the relationship between federal 
                investment in public health and the incidence of cardiovascular diseases across six 
                countries — the United States, Brazil, Japan, Australia, Cuba, and Finland — focusing on 
                their healthcare investments from 2000 to 2020.
            </p>

               
            <p>Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide, prompting nations 
                to invest heavily in public health initiatives aimed at prevention and treatment (
                Benjamin et al., 2019). Figure 1 illustrates the evolution of CVD rates in five 
                countries between 2000 and 2020. Despite a reduction in CVD mortality across all the 
                countries analyzed, it remains higher in Brazil and Cuba and lower in Japan and Australia.
            </p>    

            <div id="plotly-graph">
                <!-- Figure line_cvd_2000_2020.html here -->
                <iframe src="line_cvd_2000_2020.html" width="100%" height="800px" frameborder="0"></iframe>
            </div>

            <p>Figure 1: Cardiovascular disease (CVD) mortality rate per 100,000 people from 2000 to 2020 for Australia, 
                Cuba, Japan, Brazil, Finland, and the United States. The interactive plot allows you to hover over data 
                points for specific values and compare trends across countries over time.
            </p>

            <p>When we consider the healthcare expenditure (as percentage of GDP), we observe that along the time, 
                the investiment is increasing for all countries analyzed but USA has the highest healthcare expenditure, 
                while Finland and Brazil present the lowest values.
            </p>
        
            <p>A comparative analysis, showed in figure 3, reveals diverse outcomes among the six countries, 
                highlighting the complex relationship between healthcare spending and 
                CVD incidence. Despite high healthcare expenditures, the United States 
                has shown only a modest decrease in CVD mortality rates (Frieden & Berwick, 2011), 
                suggesting that high spending alone does not guarantee optimal outcomes. 
                In contrast, Brazil's focus on preventive care and health education has led 
                to a notable reduction in CVD mortality rates, emphasizing the importance of 
                efficient resource allocation (Ribeiro et al., 2016). This demonstrates that 
                middle-income nations can achieve significant improvements through targeted 
                public health strategies. Japan's consistently low CVD incidence, attributed 
                to a combination of factors including a healthy diet, active lifestyle, and 
                emphasis on preventive care (Iso, 2011), further underscores the importance 
                of cultural factors and lifestyle in CVD prevention.
            </p>       
        
            <p>The experiences of Australia, Cuba, and Finland provide additional insights 
                into effective strategies for reducing CVD incidence. Australia has demonstrated 
                a strong correlation between increased healthcare spending and reduced CVD mortality, 
                highlighting the importance of well-targeted public health investments (Australian Institute 
                of Health and Welfare, 2021). Cuba's remarkable success in reducing CVD mortality rates, 
                despite limited economic resources, shows that efficient allocation of resources can be 
                crucial (Cooper et al., 2006). This underscores the potential for significant health 
                improvements even with constrained budgets. Finland's comprehensive approach, including 
                the North Karelia Project, serves as a model for other countries. It emphasizes the 
                importance of long-term commitment to public health initiatives and addressing social 
                determinants of health, such as education, housing, and employment (Puska, 2002).
            </p>

            
            <div id="plotly-graph">
                <!-- Figure line_hc_2000_2020.html here -->
                <iframe src="line_hc_2000_2020.html" width="100%" height="800px" frameborder="0"></iframe>
            </div>
            
            <p>Figure 2: Investiment in healthcare from 2000 to 2020 for Australia, 
                Cuba, Japan, Brazil, Finland, and the United States. The interactive plot allows you to 
                hover over data points for specific values and compare trends across countries over time.
            </p>
    
            <p>Across all studied countries, the role of technology in CVD prevention and treatment has 
                become increasingly important. Investments in digital health infrastructure, telemedicine, 
                and mobile health applications have improved access to healthcare services, particularly in 
                rural and underserved areas (World Health Organization, 2019). Additionally, research in 
                genomics and precision medicine has led to targeted interventions and personalized treatment 
                plans, enhancing the effectiveness of CVD prevention and treatment (National Institutes of 
                Health, 2020). Community-based initiatives, such as public health campaigns and health 
                education programs, have also been effective in promoting healthy lifestyles and reducing 
                CVD risk factors (Centers for Disease Control and Prevention, 2020).
            </p>

            <div id="plotly-graph">
                <!-- Figure cvd_hc.html here -->
                <iframe src="cvd_hc.html" width="100%" height="600px" frameborder="0
                                "></iframe>
            </div>

            <p>Figure 3: Comparative analysis of cardiovascular disease (CVD) mortality rates and healthcare expenditure as a 
                percentage of GDP for Australia, Cuba, Japan, Brazil, Finland, and the United States. The interactive plot 
                allows you to explore the relationship between healthcare spending and CVD outcomes across countries.
            </p>

            <p>In conclusion, the comparative analysis of healthcare expenditure and CVD incidence across six countries 
                reveals that higher spending alone does not necessarily lead to better health outcomes. Effective resource 
                allocation, preventive care, and addressing social determinants of health are crucial factors in reducing 
                CVD mortality rates. The experiences of countries like Brazil, Cuba, and Finland demonstrate that even 
                with limited economic resources, significant health improvements can be achieved through targeted public 
                health strategies. These findings highlight the importance of a holistic approach to public health investment, 
                focusing not only on the amount spent but also on how resources are utilized to promote health and prevent disease.
            </p>

            <p>References:
                <ul>
                    <li>Australian Institute of Health and Welfare. (2021). Australia's health 2020. Retrieved from <a href="https://www.aihw.gov.au/reports/australias-health/australias-health-2020/contents/summary" target="_blank">AIHW</a>.</li>
                    <li>Benjamin, E. J., Muntner, P., Alonso, A., et al. (2019). Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation, 139(10), e56-e528.</li>
                    <li>Centers for Disease Control and Prevention. (2020). Million Hearts: Strategies to reduce the prevalence of cardiovascular disease. Retrieved from <a href="https://www.cdc.gov/millionhearts/index.html" target="_blank">CDC</a>.</li>
                    <li>Cooper, R. S., Kennelly, J. F., Durazo-Arvizu, R., et al. (2006). Cardiovascular disease and associated risk factors in Cuba: Prospects for prevention and control. American Journal of Public Health, 96(1), 94-101.</li>
                    <li>Frieden, T. R., & Berwick, D. M. (2011). The “Million Hearts” initiative—preventing heart attacks and strokes. New England Journal of Medicine, 365(13), e27.</li>
                    <li>Iso, H. (2011). Lifestyle and cardiovascular disease in Japan. Journal of Atherosclerosis and Thrombosis, 18(2), 83-88.</li>
                    <li>National Institutes of Health. (2020). Precision Medicine Initiative. Retrieved from <a href="https://allofus.nih.gov/" target="_blank">NIH</a>.</li>
                    <li>Puska, P. (2002). Successful prevention of non-communicable diseases: 25-year experiences with North Karelia Project in Finland. Public Health Medicine, 4(1), 5-7.</li>
                    <li>Ribeiro, A. L., Duncan, B. B., Brant, L. C., et al. (2016). Cardiovascular health in Brazil: Trends and perspectives. Circulation, 133(4), 422-433.</li>
                    <li>World Health Organization. (2019). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Retrieved from <a href="https://www.who.int/publications/i/item/9789241506236" target="_blank">WHO</a>.</li>
                </ul>
            </p>
        </article>
    </main>
</body>
</html>

